Correction to: Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion

Affiliations

• ¹ Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, USA.
• ² Trudeau Institute, Saranac Lake, NY, USA.
• ³ US Army Institute of Surgical Research, Ft. Sam Houston, TX, USA.
• ⁴ Brooke Army Medical Center, Ft. Sam Houston, TX, USA.
• ⁵ Greehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX, USA.
• ⁶ Department of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.
• ⁷ Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA.
• ⁸ Innate Pharma Research Laboratories, Innate Pharma, CNRS, INSERM, CIML, and Assistance Publique des Hôpitaux de Marseille, Hôpital de la Timone, Immunology, Marseille-Immunopôle, Aix Marseille University, Marseille, France.
• ⁹ Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, USA. [email protected].